Clinical trial
A Double-Blind, Randomized, Placebo-Controlled Study of the Efficacy and Safety…
NCT00254436 · M.D. Anderson Cancer Center, Other · Terminated
Key facts
| NCT number | NCT00254436 |
|---|---|
| Title | A Double-Blind, Randomized, Placebo-Controlled Study of the Efficacy and Safety of Weekly Procrit Given to Gastric or Rectal Patients |
| Official title | A Double-Blind, Randomized, Placebo-Controlled Study of the Efficacy and Safety of Epoetin Alfa Administered Weekly in Patients With Gastric or Rectal Cancers Undergoing Preoperative Chemoradiation Followed by Surgery |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Collaborators | Ortho Pharmaceuticals Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Gastrointestinal Cancer, Rectal Cancer |
| Intervention type | Drug |
| Interventions | Procrit (epoetin alfa) |
| Enrollment | 50 |
| Start date | Oct 31, 2001 |
| Primary completion | Jun 29, 2004 |
| Completion | Jun 29, 2004 |
| First posted | Nov 16, 2005 |
| Last update posted | Oct 25, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: